The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Peethaambaran Kunnathoor, Chennai Friday, March 28, 2025, 08:00 Hrs [IST] ...

Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

The tablets are used for treating signs and symptoms of allergic rhinitis, chronic idiopathic urticaria and bronchial asthma. In a separate raid, the DCA conducted raids on clinics operated by two ...

Untreated irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) can lead to many complications like malnutrition, rectal prolapse, and more. Both IBS-C and ...

The cause of chronic hives is usually unknown. Studies suggest that between 80% and 90% of cases are idiopathic. Even with extensive diagnostics, a cause may never be found. Dermatographism is a form ...

For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H 1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase ...

Appropriate use Seasonal and perennial (year-round) allergic rhinitis and chronic idiopathic urticaria (hives) The over-the-counter (OTC) solution is labeled only for use in children 2 years of age ...

Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, reduced itch and hives in patients with chronic spontaneous urticaria and showed a favorable safety profile at week 12 in two trials.

Chronic stress is a common risk factor for stroke, but may not affect everyone the same way. Stress is inherently subjective. For some people, stress could be caused by an important work deadline ...

Phase III REMIX-1 and REMIX-2 trials demonstrated that remibrutinib, an oral BTK inhibitor, significantly reduced chronic spontaneous urticaria symptoms in patients unresponsive to second-generation ...

Patients with chronic spontaneous urticaria typically receive second-generation H 1-antihistamines as first-line therapy, but more than 50% continue to have symptoms. New research findings on ...